Laddar...
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks
At the moment, little treatment options are available for Duchenne muscular dystrophy (DMD). The absence of the dystrophin protein leads to a complex cascade of pathogenic events in myofibres, including chronic inflammation and oxidative stress as well as altered metabolism. The attention towards di...
Sparad:
| I publikationen: | Pharmacol Res |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier Ltd.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261230/ https://ncbi.nlm.nih.gov/pubmed/32485610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104917 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|